首页 › 前体T细胞淋巴母细胞白血病/淋巴瘤 › 得克萨斯州 › Houston
Houston TX 前体T细胞淋巴母细胞白血病/淋巴瘤临床试验
8项针对 前体T细胞淋巴母细胞白血病/淋巴瘤的研究正在 Houston及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本(英文)
正在为研究招募参与者?将此页面置顶展示 — $99 / 30天 →
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
招募中2 期
- MD Anderson Cancer Center, Houston
A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy)
招募中2 期
- MD Anderson Cancer Center, Houston
Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma
招募中1 期
- MD Anderson Cancer Center, Houston
Venetoclax, Dexamethasone, Bortezomib, and Daratumumab For The Treatment Of Adolescent And Young Adults With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And T-cell Acute Lymphoblastic Lymphoma
招募中1 期
- UT MD Anderson, Houston
Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen
招募中1 期
- Houston Methodist Hospital, Houston
- Texas Children's Hospital, Houston
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
招募中2 期
- M D Anderson Cancer Center, Houston
A Registry for People With T-cell Lymphoma
招募中观察性研究
- MD Anderson Cancer Center (Data Collection Only), Houston
Novel Unedited Allo Cell Therapy For High Risk T-Cell Malignancies Using CD7-Specific Car T Cells
招募中1 期
- Houston Methodist Hospital, Houston
- Texas Children's Hospital, Houston
其他城市的 前体T细胞淋巴母细胞白血病/淋巴瘤试验
- New York City, NY6 项研究
- Columbus, OH5 项研究
- Washington, DC4 项研究
- Philadelphia, PA4 项研究
- Baldwin Park, CA3 项研究
- St. Louis, MO3 项研究
- Boston, MA3 项研究
- Edison, NJ3 项研究
- Queens, NY3 项研究
- New Rochelle, NY3 项研究
- Staten Island, NY3 项研究
- East Norwalk, CT3 项研究
Houston的其他研究
- 非小细胞肺癌145 项研究
- 乳腺癌126 项研究
- 癌症(所有类型)121 项研究
- 转移性癌症104 项研究
- 结直肠癌102 项研究
- 卵巢癌89 项研究
- 急性髓系白血病85 项研究
- 肺癌78 项研究
- 前列腺癌76 项研究
- 子宫内膜癌68 项研究
- 胰腺癌61 项研究
- 黑色素瘤59 项研究
数据来自 ClinicalTrials.gov,检索日期:2026年10月5日。每项研究自行设定入选标准,由研究团队决定谁能参与。